Download PDF
Nervenheilkunde 2011; 30(08): 04
DOI: 10.1055/s-0038-1628407
Kasuistik
Schattauer GmbH

Online Literatur zum Artikel M. Schmid et al.: Hypersexualität

M. Schmid
,
B. J. Connemann
,
H.-J. Maxon
Further Information

Publication History

Publication Date:
23 January 2018 (online)

   Permissions and Reprints

 

 

  • Literatur

  • 1 Argiolas A, Melis MR. The neurophysiology of the sexual cycle. J Endocrinol Invest 2003; 26 (Suppl. 03) 20-2.
    PubMedGoogle Scholar
  • 2 Arzneimittelkommission der deutschen Ärzteschaft. Hypersexualität unter Aripiprazol (Abilify®). Deutsches Ärzteblatt 2006; 103 (51–52): A3518.
    Google Scholar
  • 3 Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol Clin Exp 2008; 23: 201-9.
    CrossrefPubMedGoogle Scholar
  • 4 Dossenbach M. et al. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol 2005; 08 (02) 195-201.
    CrossrefPubMedGoogle Scholar
  • 5 Freeman B, Levy W. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma. J Sychiatric Practice 2007; 13 (02) 120-4.
    Google Scholar
  • 6 Frei A. Induktion paraphiler Handlungen als unerwünschte Wirkung der Neueinstellung auf Aripiprazol?. Schweizer Archiv für Neur und Psych 2010; 161 (02) 69-71.
    Google Scholar
  • 7 Jenssens L. et al. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study. BMC Psychiatry 2006; 08: 95.
    Google Scholar
  • 8 Kelly DL, Conley R. Sexuality and schizophrenia: a review. Schizophr Bull 2000; 30 (04) 767-79.
    Google Scholar
  • 9 Macdonald et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. BJP 2003; 182: 50-6.
    CrossrefPubMedGoogle Scholar
  • 10 Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000; 57 (11) 1012-30.
    CrossrefPubMedGoogle Scholar
  • 11 Mir A. et al. Change in sexual dysfunction with aripiprazole: a switching or add-on study. J Psychopharmacol 2008; 22 (03) 244-53.
    CrossrefPubMedGoogle Scholar
  • 12 Schlachetzki JCM, Langosch JM. Aripiprazol induced hypersexuality in a 24-year-old female patient with schizoaffective disorder?. J Clin Psychopharmacology 2008; 28 (05) 567-8.
    CrossrefPubMedGoogle Scholar
  • 13 Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007; 64 (08) 1089-96.
    CrossrefPubMedGoogle Scholar
  • 14 Weydt P. et al. Hypogonadism and gynecomastia with duloxetine. Pharmacopsychiatry. 2011 Feb. 4; Epub ahead of print..
    PubMedGoogle Scholar
  • 15 Wood M, Reavill C. Aripiprazole acts as a selective dopamine D2 receptor partial agonist. Expert Opin Investig Drugs 2007; 16 (06) 771-5.
    CrossrefPubMedGoogle Scholar